BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6326372)

  • 1. [Protecting chickens against Marek's disease under laboratory conditions by the administration of Marvak, a Czechoslovak produced vaccine and vaccine imported from East Germany].
    Jurajda V; Pospísil Z; Pokorná B; Salaj J
    Vet Med (Praha); 1984 Mar; 29(3):171-80. PubMed ID: 6326372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Postvaccination viremia in breeding flocks of layers and broilers after vaccination against Marek's disease of fowl].
    Jurajda V; Salaj J; Pospísil Z
    Vet Med (Praha); 1984 Dec; 29(12):719-28. PubMed ID: 6098065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of short-term isolation of vaccinated chicks on the incidence of Marek's disease].
    Pospísil Z; Jurajda V; Jurák E; Zendulková D
    Vet Med (Praha); 1986 Sep; 31(9):541-50. PubMed ID: 3020763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of a Bulgarian vaccine against Marek's disease in broilers].
    Kasabov R; Nikolova M; Obreshkov K; Mentov V
    Vet Med Nauki; 1976; 13(3):53-8. PubMed ID: 181895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection provided by Rispens CVI988 vaccine against Marek's disease virus isolates of different pathotypes and early prediction of vaccine take and MD outcome.
    Ralapanawe S; Walkden-Brown SW; Renz KG; Islam AF
    Avian Pathol; 2016; 45(1):26-37. PubMed ID: 26503904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
    Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
    Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T; Walkden Brown SW; Renz KG; Fakhrul Islam AF; Ralapanawe S
    Avian Pathol; 2013 Dec; 42(6):516-26. PubMed ID: 24098951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
    Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
    Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced shedding of Marek's disease virus from feather follicles of bivalent vaccinated chickens.
    Pruthi AK; Gupta RK; Sadana JR
    Indian J Exp Biol; 1987 Jun; 25(6):405-7. PubMed ID: 2831141
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of the turkey herpesvirus vaccine by the aerogenic route for the prevention of Marek's disease.
    Eidson CS; Kleven SH
    Dev Biol Stand; 1976; 33():370-5. PubMed ID: 182596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experiments with the simultaneous or combined vaccination of chicks against Marek's disease and Newcastle disease].
    Cholakova R; Stanilov Kh; Aleksiev N
    Vet Med Nauki; 1978; 15(7):19-26. PubMed ID: 219586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the pathology of Marek's disease following challenge in chicks vaccinated with three different vaccines.
    Pruthi AK; Gupta RK; Sadana JR
    J Comp Pathol; 1989 Oct; 101(3):295-305. PubMed ID: 2555401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.